DAL
85
2
GME
71
6
CHRW
64
13
STZ
52
2
CMA
67
3
STX
55
-5
EQIX
62
-3
IPG
49
-5
NWSA
78
-19
BEN
40
4
NWS
79
-4
WBA
53
6
IRM
42
-4
FCX
61
-2
TXN
55
-4
CNP
46
-4
BAC
57
3
GM
72
3
GOOGL
64
5
PLD
46
-4
DAL
85
2
GME
71
6
CHRW
64
13
STZ
52
2
CMA
67
3
STX
55
-5
EQIX
62
-3
IPG
49
-5
NWSA
78
-19
BEN
40
4
NWS
79
-4
WBA
53
6
IRM
42
-4
FCX
61
-2
TXN
55
-4
CNP
46
-4
BAC
57
3
GM
72
3
GOOGL
64
5
PLD
46
-4
Financhill
Back

Collegium Pharmaceutical Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
33

COLL
Collegium Pharmaceutical

Last Price:
31.41
Seasonality Move:
32.65%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Collegium Pharmaceutical Price Quote

$31.41
-0.77 (-2.39%)
(Updated: November 12, 2024 at 5:55 PM ET)

Collegium Pharmaceutical Key Stats

Sell
33
Collegium Pharmaceutical (COLL) is a Sell
Day range:
$31.85 - $34.04
52-week range:
$24.48 - $42.29
Dividend yield:
0%
P/E ratio:
24.95
P/S ratio:
2.47
P/B ratio:
4.43%
Volume:
698K
Avg. volume:
385.9K
1-year change:
31.45%
Market cap:
$1B
Revenue:
$566.8M
EPS:
$2.33

How Much Does Collegium Pharmaceutical Make?

Is Collegium Pharmaceutical Growing As A Company?

Collegium Pharmaceutical Stock Price Performance

What Is Collegium Pharmaceutical 52-Week High & Low?

Collegium Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Collegium Pharmaceutical?

Is Collegium Pharmaceutical Cash Flow Positive?

  • What Is COLL Cash Flow From Operations?
    Cash flow from operations (TTM) is $193.7M
  • What Is Collegium Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$87.2M
  • What Is Collegium Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$301.1M

Collegium Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    COLL return on invested capital is 9.91%
  • What Is Collegium Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 7.23%
  • What Is COLL Return On Equity?
    ROE is a measure of profitability and is 42.3%

Collegium Pharmaceutical Earnings Date & Stock Price

Collegium Pharmaceutical Competitors

Collegium Pharmaceutical Dividend Yield

Collegium Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: -49.06% 1.1%
Revenue: 16.53% 2.4%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 43.25
Upside from Last Price: 34.4%

Major Shareholders

  • How many COLL shares are owned by institutional investors?
    57M COLL shares are owned by institutional investors
  • How many COLL shares are owned by insiders?
    1.8M COLL shares are owned by insiders